Agilent and pathai partner to deliver ai-powered assay development solutions for biopharma research and clinical applications

Santa clara, calif.--(business wire)--agilent technologies inc. (nyse: a) today announced a strategic partnership with pathai, a leading provider of ai-powered research tools and services for pathology, to deliver biopharmaceutical organizations a solution that combines agilent's assay development expertise and pathai's algorithm development capabilities.
A Ratings Summary
A Quant Ranking